Rayconda Internal Medicine is categorized under Doctors in Fayetteville, NC .
Rayconda Internal Medicine was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Jagdish Lal, Office Manager at the company’s single location by writing to 6958 Nexus Court # 101, Fayetteville, North Carolina NC 28304 or by phoning (910) 487-1009. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Rayconda Internal Medicine |
| Contact Person: | Jagdish Lal, Office Manager |
| Address: | 6958 Nexus Court # 101, Fayetteville, North Carolina 28304 |
| Phone Number: | (910) 487-1009 |
| Website Address: | raycondainternalmedicine.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Rayconda Internal Medicine was started in 0 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Jagdish Lal, Office Manager for inquiries that concern Rayconda Internal Medicine by calling the company number (910) 487-1009, as your correspondence is most welcome. Additionally, the physical location of the single location of Rayconda Internal Medicine can be found at the coordinates 35.03555,-79.01302 as well as the street address 6958 Nexus Court # 101 in Fayetteville, North Carolina 28304.
For its online presence, you may visit Rayconda Internal Medicine’s website at raycondainternalmedicine.com and engage with its social media outlets through on Twitter and on Facebook.